The Journal of Allergy and Clinical Immunology
Volume 124, Issue 3 , Pages 428-433 , September 2009

Unmet needs in severe chronic upper airway disease (SCUAD)

  • Jean Bousquet, MD

      Affiliations

    • University Hospital, Montpellier, France
    • Corresponding Author InformationReprint requests: Jean Bousquet, MD, PhD, Service des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, 371, Avenue Doyen Gaston Giraud, F-34295 Montpellier Cedex 5, France.
    • Members of the Global Allergy and Asthma European Network, supported by the European Union Framework programme for research contract no. FOOD-CT-2004-506378.
    • Members of the Board of the World Allergy Organization.
    • ,
  • Claus Bachert, MD

      Affiliations

    • UZG, University Hospital Ghent, Ghent, Belgium
    • Members of the Global Allergy and Asthma European Network, supported by the European Union Framework programme for research contract no. FOOD-CT-2004-506378.
    • ,
  • Giorgio W. Canonica, MD

      Affiliations

    • Allergy and Respiratory Diseases Clinic, University of Genova, Genova, Italy
    • Members of the Global Allergy and Asthma European Network, supported by the European Union Framework programme for research contract no. FOOD-CT-2004-506378.
    • Members of the Board of the World Allergy Organization.
    • ,
  • Thomas B. Casale, MD

      Affiliations

    • Creighton University, Omaha, Neb
    • Members of the Board of the World Allergy Organization.
    • ,
  • Alvaro A. Cruz, MD

      Affiliations

    • ProAR–FMB, Federal University of Bahia, Salvador, Brazil
    • ,
  • Richard J. Lockey, MD

      Affiliations

    • Joy McCann Culverhouse, University of South Florida College of Medicine, Tampa, Fla
    • Members of the Board of the World Allergy Organization.
    • ,
  • Torsten Zuberbier, MD

      Affiliations

    • Allergy Centre Charité, Charité–Universitätsmedizin Berlin, Berlin, Germany
    • Members of the Global Allergy and Asthma European Network, supported by the European Union Framework programme for research contract no. FOOD-CT-2004-506378.
    • ,
  • on behalf of the extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asthma Study Group

      Affiliations

    • The names of the rest of the members of the Allergic Rhinitis and its Impact on Asthma Study Group can be found in the Acknowledgments section.

Received 24 February 2009 ,Revised 26 May 2009 ,Accepted 2 June 2009.

References 

  1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(suppl):S147–S334
  2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(suppl 86):8–160
  3. Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Global Alliance Against Chronic Respiratory Diseases. World Health Organization, Geneva; 2007;
  4. Santos CB, Pratt EL, Hanks C, McCann J, Craig TJ. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol. 2006;97:579–589671
  5. Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62:367–372
  6. Bousquet J, Lund VJ, Van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT, et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy. 2003;58:733–741
  7. White P, Smith H, Baker N, Davis W, Frew A. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?. Clin Exp Allergy. 1998;28:266–270
  8. Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy. 2008;63:842–853
  9. Rondon C, Romero JJ, Lopez S, Antunez C, Martin-Casanez E, Torres MJ, et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol. 2007;119:899–905
  10. Bousquet J, Bieber T, Fokkens W, Kowalski ML, Humbert M, Niggemann B, et al. Important questions in allergy: novel research areas. Allergy. 2008;63:143–147
  11. Bousquet PJ, Leynaert B, Neukirch F, Sunyer J, Janson CM, Anto J, et al. Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy. 2008;63:1301–1309
  12. Weinmayr G, Forastiere F, Weiland SK, Rzehak P, Abramidze T, Annesi-Maesano I, et al. International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur Respir J. 2008;32:1250–1261
  13. Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol. 2006;118:985–998
  14. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 1007. Rhinology. 2007;45(suppl 20):1–136
  15. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006;118(suppl):S17–S61
  16. Borish L. Maybe rhinitis, maybe sinusitis, maybe rhinitis and sinusitis, but certainly not rhinosinusitis!. J Allergy Clin Immunol. 2005;116:1269–1271
  17. Alobid I, Bernal-Sprekelsen M, Mullol J. Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy. 2008;63:1267–1279
  18. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104–109
  19. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–1289
  20. Bachert C, Zhang N, Patou J, van Zele T, Gevaert P. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol. 2008;8:34–38
  21. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Dahlen B, Dahlen S, et al. Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI/GA2LEN guideline. Allergy. 2007;62:1111–1118
  22. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118:773–788
  23. Moscato G, Vandenplas O, Gerth Van Wijk R, Malo JL, Quirce S, Walusiak J, et al. Occupational rhinitis. Allergy. 2008;63:969–980
  24. Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64:123–148
  25. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–1057
  26. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol. 2006;6:29–36
  27. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107:73–80

 Disclosure of potential conflict of interest: J. Bousquet has received fees for lectures or participation on advisory boards from Stallergenes, Schering-Plough, UCB, Merck, Sanofi-Aventis, and Allmiral. T. B. Casale has received research support through his institution from Pfizer and Stallergenes. A. A. Cruz is a consultant for AstraZeneca; has received honoraria, travel grants, or other grants from Mantecorp, CHIESI, and Novartis; and has received research support from GlaxoSmithKline, Wellcome Trust, FAPESB (Brazil), and CNPq (National Research Council, Brazil). T. Zuberbier is a consultant for Schering-Plough, Novartis, Leti, Stallergenes, Bayer Schering, Ansell, Kryolan, UCB, Merck, Sharp & Dohme, and Procter & Gamble. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)00982-8

doi: 10.1016/j.jaci.2009.06.027

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 3 , Pages 428-433 , September 2009

Article Tools